Literature DB >> 20488670

F15599, a preferential post-synaptic 5-HT1A receptor agonist: activity in models of cognition in comparison with reference 5-HT1A receptor agonists.

Ronan Depoortère1, Agnès L Auclair, Laurent Bardin, Francis C Colpaert, Bernard Vacher, Adrian Newman-Tancredi.   

Abstract

We assessed the activity of F15599, a selective and high efficacy 5-HT(1A) agonist that preferentially activates post- versus pre-synaptic receptors, in rat cognition/memory models. F15599 (0.16 mg/kg i.p.) partially alleviated detrimental effects of phencyclidine on working and reference memory deficit in a hole-board model. It also attenuated phencyclidine-induced deficit of cognitive flexibility in a reversal learning task, without effects of its own. F13714 (0.04 mg/kg) a chemical congener of F15599, and 8-OH-DPAT (0.01 or 0.16), were inactive against these phencyclidine-induced deficits, and/or even worsened basal performances. F15599 (0.04-2.5) was less disruptive than F13714 (0.005-0.16) or 8-OH-DPAT (0.01-0.63), on basal performance in models of attention (5-choice serial reaction time task) and working memory (delayed non-matching to position). Finally, unlike either comparator, F15599 reduced PPI with modest potency and only partially. To conclude, F15599, in models of memory/cognition, has a more favourable profile than F13714 and 8-OH-DPAT. This suggests that preferential activation of post-synaptic 5-HT(1A) receptors could prove useful in pathologies characterized by cognitive/memory deficiencies, such as schizophrenia and depression. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488670     DOI: 10.1016/j.euroneuro.2010.04.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  22 in total

1.  Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice.

Authors:  Dirson João Stein; Klaus A Miczek; Aldo Bolten Lucion; Rosa Maria Martins de Almeida
Journal:  Psychopharmacology (Berl)       Date:  2013-07-05       Impact factor: 4.530

2.  In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging.

Authors:  Benjamin Vidal; Sylvain Fieux; Jérôme Redouté; Marjorie Villien; Frédéric Bonnefoi; Didier Le Bars; Adrian Newman-Tancredi; Nicolas Costes; Luc Zimmer
Journal:  Neuropsychopharmacology       Date:  2018-07-06       Impact factor: 7.853

Review 3.  5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function.

Authors:  Alvaro L Garcia-Garcia; Adrian Newman-Tancredi; E David Leonardo
Journal:  Psychopharmacology (Berl)       Date:  2013-12-12       Impact factor: 4.530

4.  The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.

Authors:  M Horiguchi; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2012-01-07       Impact factor: 4.530

5.  Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.

Authors:  N P van Goethem; R Schreiber; A Newman-Tancredi; M Varney; J Prickaerts
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Authors:  Saki Shimizu; Yukihiro Ohno
Journal:  Aging Dis       Date:  2012-11-29       Impact factor: 6.745

7.  Future directions for serotonin and antidepressants.

Authors:  Francesc Artigas
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

Review 8.  Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

Authors:  Pau Celada; Analía Bortolozzi; Francesc Artigas
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

9.  The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress.

Authors:  Monika Głuch-Lutwin; Kinga Sałaciak; Alicja Gawalska; Marek Jamrozik; Joanna Sniecikowska; Adrian Newman-Tancredi; Marcin Kołaczkowski; Karolina Pytka
Journal:  Psychopharmacology (Berl)       Date:  2021-05-10       Impact factor: 4.530

Review 10.  Impact of specific serotonin receptor modulation on behavioral flexibility.

Authors:  Bryan D Alvarez; Cheyenne A Morales; Dionisio A Amodeo
Journal:  Pharmacol Biochem Behav       Date:  2021-07-24       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.